PRS:仅用皮瓣重建乳房的新技术!双侧叠加式皮瓣乳房再造的早期经验

2021-03-17 MedSci原创 MedSci原创

这项技术解决了重建时所需额外皮肤的需求,以帮助创建更自然的上睑下垂和额外体积的乳房包膜,以帮助创建适合身体的乳房大小,同时避免连续的脂肪移植。

这项技术解决了对重建时所需额外皮肤的需求,以帮助创建更自然的乳房下垂形态和额外体积的乳房包膜,以帮助创建适合身体的乳房丘,同时避免连续的脂肪移植。

近年来,随着显微外科技术的进步、可供选择的穿支皮瓣经验的增加以及联合手术的使用,使用四个皮瓣重建双乳房(双侧叠加式皮瓣)已成为可行的方法。这篇文章描述了双侧叠加式皮瓣乳房再造的早期经验。

从2014年1月至2018年10月,共计50例双侧叠加式皮瓣手术。所有重建均以延迟方式进行,平均手术时间为10h。大多数乳房(94%)采用腹壁深下穿支皮瓣联合深动脉穿支皮瓣再造。大多数(91.5%)皮瓣直接与内乳房血管吻合。两个皮瓣中较大的一个通常位于下方(66%),但有显著的嵌入性差异。

所有双侧叠加式皮瓣乳房再造均由两名联合外科医生完成。值得注意的是,单靠一名外科医生在合理的时间内进行这项手术可能是不可行的。手术包括从大腿切取双侧DIEP和/或保留肌肉的TRAM皮瓣和双侧深动脉穿支皮瓣。通常情况下,一名外科医生会先准备作乳房囊腔,显露一侧的乳房内血管(通常是先暴露左侧),而第二名外科医生会开始腹部皮瓣的解剖。通常在30到45分钟内完成乳房囊腔和血管准备。一旦完成,就可以开始同时剥离深动脉穿支皮瓣。通常,双侧乳房的DIEP和深动脉穿支皮瓣均在显微手术前准备好。值得注意的是,研究者已经观察到,椭圆形的深动脉穿支皮瓣可以用来重建乳房的下极吊带;然而,同样地,它也可以用来提供上极饱满,当斜面时,它可以很好地渐变到天然胸壁上。

DIEP和深动脉穿支皮瓣通常需要深度缝合,以减少两皮瓣之间可触及的裂隙的机会。皮肤深度皮质化的数量差异很大,取决于几个因素,包括放射性皮肤损伤的程度和需要切除的本地皮肤,是否有预先的包膜扩张,以及重建的目标。

双侧堆叠式皮瓣乳房再造的一个优点是,除了体积之外,可以转移更多的皮肤到胸部,从而更好地重塑乳房自然的下垂形态。此外,它还允许放置额外的加温装置,以帮助患者调节体温。除了新重建的乳房切口用Xeroform包扎外,所有切口通常都用氰基丙烯酸酯皮肤粘合剂包扎,并预防性涂抹抗生素软膏。

200个皮瓣中有5个皮瓣丢失(2.5%)。

与皮瓣相关的问题需要收回七次,其中包括两次阴性探查和一次皮瓣抢救。最常见的非皮瓣相关并发症是大腿伤口(总共17处,8处需要手术)

作者的早期经验表明早期的双侧堆叠式皮瓣乳房重建术的经验表明,这是一种高度专业化的手术,可能适合那些希望避免植入物且在供体腹部组织最少的情况下寻求乳房重建术的年轻患者双侧叠加式皮瓣乳房重建术是一种有效的工具,可以在可接受的显微手术风险和可接受的并发症情况下进行在每个再造乳房中使用的多个穿支瓣可以转移额外的体积和皮肤,在单个阶段创造出美观的自然下垂的乳房形状

更多的研究将需要更好地理解,特别是与替代方法相比,降低了二次皮瓣流入灌注压力和减少成本。随着经验的增加,可以结合各种其他供区部位,以适应患者独特的身体习惯。

此外,对于供体部位有不同的选择。可以采用一种创新的方法,不仅根据患者的具体情况选择理想的穿支皮瓣,而且还能尝试降低供体部位的发病率。这是为了改善乳房和整个躯干的整体美容效果。

原始文献:

Haddock Nicholas T,Suszynski Thomas M,Teotia Sumeet S,Consecutive Bilateral Breast Reconstruction Using Stacked Abdominally Based and Posterior Thigh Free Flaps.[J] .Plast Reconstr Surg, 2021, 147: 294-303.

DOI: 10.1097/PRS.0000000000007548

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1903861, encodeId=184519038616a, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Fri Aug 13 15:30:03 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941626, encodeId=2d2819416261f, content=<a href='/topic/show?id=94b42361946' target=_blank style='color:#2F92EE;'>#乳房再造#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23619, encryptionId=94b42361946, topicName=乳房再造)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Wed Jan 26 15:30:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669056, encodeId=7ecf1669056f1, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sat Aug 07 01:30:03 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425644, encodeId=e2a31425644ff, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522466, encodeId=22361522466ba, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949134, encodeId=a34c9491349f, content=挺好的 至少更自然了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18df2566800, createdName=妙酒, createdTime=Thu Mar 18 01:33:29 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1903861, encodeId=184519038616a, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Fri Aug 13 15:30:03 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941626, encodeId=2d2819416261f, content=<a href='/topic/show?id=94b42361946' target=_blank style='color:#2F92EE;'>#乳房再造#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23619, encryptionId=94b42361946, topicName=乳房再造)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Wed Jan 26 15:30:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669056, encodeId=7ecf1669056f1, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sat Aug 07 01:30:03 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425644, encodeId=e2a31425644ff, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522466, encodeId=22361522466ba, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949134, encodeId=a34c9491349f, content=挺好的 至少更自然了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18df2566800, createdName=妙酒, createdTime=Thu Mar 18 01:33:29 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1903861, encodeId=184519038616a, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Fri Aug 13 15:30:03 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941626, encodeId=2d2819416261f, content=<a href='/topic/show?id=94b42361946' target=_blank style='color:#2F92EE;'>#乳房再造#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23619, encryptionId=94b42361946, topicName=乳房再造)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Wed Jan 26 15:30:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669056, encodeId=7ecf1669056f1, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sat Aug 07 01:30:03 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425644, encodeId=e2a31425644ff, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522466, encodeId=22361522466ba, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949134, encodeId=a34c9491349f, content=挺好的 至少更自然了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18df2566800, createdName=妙酒, createdTime=Thu Mar 18 01:33:29 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
    2021-08-07 kzlchina
  4. [GetPortalCommentsPageByObjectIdResponse(id=1903861, encodeId=184519038616a, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Fri Aug 13 15:30:03 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941626, encodeId=2d2819416261f, content=<a href='/topic/show?id=94b42361946' target=_blank style='color:#2F92EE;'>#乳房再造#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23619, encryptionId=94b42361946, topicName=乳房再造)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Wed Jan 26 15:30:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669056, encodeId=7ecf1669056f1, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sat Aug 07 01:30:03 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425644, encodeId=e2a31425644ff, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522466, encodeId=22361522466ba, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949134, encodeId=a34c9491349f, content=挺好的 至少更自然了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18df2566800, createdName=妙酒, createdTime=Thu Mar 18 01:33:29 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
    2021-03-19 sunylz
  5. [GetPortalCommentsPageByObjectIdResponse(id=1903861, encodeId=184519038616a, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Fri Aug 13 15:30:03 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941626, encodeId=2d2819416261f, content=<a href='/topic/show?id=94b42361946' target=_blank style='color:#2F92EE;'>#乳房再造#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23619, encryptionId=94b42361946, topicName=乳房再造)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Wed Jan 26 15:30:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669056, encodeId=7ecf1669056f1, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sat Aug 07 01:30:03 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425644, encodeId=e2a31425644ff, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522466, encodeId=22361522466ba, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949134, encodeId=a34c9491349f, content=挺好的 至少更自然了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18df2566800, createdName=妙酒, createdTime=Thu Mar 18 01:33:29 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1903861, encodeId=184519038616a, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Fri Aug 13 15:30:03 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941626, encodeId=2d2819416261f, content=<a href='/topic/show?id=94b42361946' target=_blank style='color:#2F92EE;'>#乳房再造#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23619, encryptionId=94b42361946, topicName=乳房再造)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Wed Jan 26 15:30:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669056, encodeId=7ecf1669056f1, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sat Aug 07 01:30:03 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425644, encodeId=e2a31425644ff, content=<a href='/topic/show?id=e0cae1973bb' target=_blank style='color:#2F92EE;'>#皮瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71973, encryptionId=e0cae1973bb, topicName=皮瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df03986056, createdName=sunylz, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522466, encodeId=22361522466ba, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Fri Mar 19 14:30:03 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949134, encodeId=a34c9491349f, content=挺好的 至少更自然了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18df2566800, createdName=妙酒, createdTime=Thu Mar 18 01:33:29 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
    2021-03-18 妙酒

    挺好的 至少更自然了

    0

相关资讯

游离股前外侧皮瓣修复大面积颈枕部头皮缺损1例

患者,男,38岁,因高压电击伤致意识不清2h,在当地县医院急诊予气管插管、呼吸机应用后转入我院继续治疗。查体:神志模糊,持续气管插管,呼吸机应用,双侧瞳孔直径约0.2cm,对光反应存在,腹平软,肝脾肋下未及,枕部及后颈部见约15cm×13cm头皮烧痂、缺损,局部颅骨外露伴渗出,见图1A。经我院ICU积极治疗后患者神志转清、病情转平稳,于2018年2月4日转我科进一步手术治疗。于2018年2月6日、

腓骨肌皮瓣修复6岁儿童创伤性口腔颌面部缺损:1例报告及文献复习

女,6岁,于入院前12d,左侧面部不慎被电风扇切割,导致颜面部大面积缺损,大量出血,同时伴右上肢手掌丢失。发现患儿时其呈昏迷状态,将其急诊送于当地医院行“面部外伤清创缝合术+右上肢清创术+气管切开术”;术后予以抗感染、补液、止血、营养支持、镇痛等对症治疗,全身病情稳定后转诊于我院。经查体,以“左侧颌面部外伤性软、硬组织缺损”收入院。

Ann Surg:术中使用血管加压剂不会增加自由瓣膜的损害和失败风险!

大多数的微创外科医生顾虑血管收缩药物的副作用而避免在自由瓣膜手术期间使用血管加压药物,这可能导致血管性血栓形成和皮瓣损伤。但是此前的研究尚缺乏统计学的数据来得出有意义的结论。近期,一项发表在杂志Ann Surg上的研究旨在评估缩血管药物对自由瓣结果的影响。此项研究回顾性地研究了2004年至2014年间从单一机构获得的所有游离皮瓣。当血压从基线降低> 20%时,静脉予以推注血管加压药物。手术后

Cell Death Dis:FGF21可增加移植皮瓣的存活预后

随机皮瓣,由于其易得且无轴向血管限制的特点而常被用于外科手术——组织重建。而缺血性坏死则是一种常见的并发症,尤其容易出现在皮瓣的远端。既往研究表明,FGF21可以促进血管生成并可预防缺血性心血管疾病,但FGF21对皮瓣存活的影响尚不明确。在本研究中,研究人员使用大鼠随机皮瓣模型,发现FGF21在成功存活的皮瓣中的表达量显著增加,提示FGF21可能对皮瓣的存活起关键作用。随后研究人员通过实验进一步来

BMC Cancer:会阴部肿瘤切除术后,植入皮瓣的结局观察

对会阴部癌症患者进行皮瓣重建,术后患者的结局和生活质量如何没有数据调查。研究者进行了一项研究评估晚期或复发性会阴部恶性肿瘤患者性行肌皮/皮肤皮瓣植入后的结局。该研究共纳入36名患者,其中 58.33 %的患者使用股前外侧皮瓣 (ALT),16.67 %的患者使用阴股沟皮瓣(PTF),11.11 %的患者使用腹壁下动脉穿支皮瓣 (DIEP),2.78 %的患者使用股薄肌肌皮瓣, 11.11 %的患者

Int Oral Max Surg: 股骨外侧髁微血管皮瓣重建下颌髁突

股骨外侧髁(LFC)皮瓣是2015年首次报道的手部手术中治疗骨髓炎的新皮瓣。

拓展阅读

乳房重建90 天时的临床和健康相关生活质量结果

在胸前放置组织扩张器进行两期植入性乳房重建可潜在地减少胸壁发病率和术后疼痛。

PRS:植入型乳房重建术中放射后包膜挛缩的处理和结果。

在放射治疗中,乳房重建通常避免植入植入物,主要是因为基于植入物的乳房重建存在包膜挛缩的风险。

PRS:植入物方案改良,乳房重建的成本更低了!

采用下方脱细胞真皮基质和上部Vicryl网片重建胸前乳房是一种安全的技术,它降低了与支撑材料相关的材料成本,并使外科医生能够精确地控制植入物的囊腔容积和位置。

PRS:乳房重建选什么假体?毛面组织扩张器会影响二期假体乳房重建的结果吗?

组织扩张器的类型可能影响二期植入物乳房重建的效果,微毛面扩张器和粗毛面扩张器的安全性基本可以接受。

J Natl Cancer Inst:乳房重建后放疗的相关并发症及病人报告结局

该前瞻性多中心研究对比了全乳切除+乳房重建术后放疗或不放疗的乳腺癌患者的并发症及病人报告结局指标。

[CBCSYC2017]任国胜教授:推广乳腺癌乳房重建术,任重而道远

第五届全国乳腺癌中青年专家论坛暨第三届天津乳腺癌多学科综合诊疗论坛于11月3日-4日在天津召开。《肿瘤瞭望》特邀中国抗癌协会乳腺癌专业委员会主任委员任国胜教授回顾和展望国内乳腺癌乳房重建相关进展。